Drug Allergy: Then, Now, and Next

Kimberly G. Blumenthal; Anca M. Chiriac; David A. Khan

doi:10.1016/j.jaip.2022.11.013

Drug Allergy: Then, Now, and Next

Kimberly G. Blumenthal, Anca M. Chiriac, David A. Khan

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	429-430
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	11
Issue number	2
DOIs	https://doi.org/10.1016/j.jaip.2022.11.013
State	Published - Feb 2023

ASJC Scopus subject areas

Immunology and Allergy

Access to Document

10.1016/j.jaip.2022.11.013

Cite this

@article{242568292ae84164a0901db02893f9e3,

title = "Drug Allergy: Then, Now, and Next",

author = "Blumenthal, {Kimberly G.} and Chiriac, {Anca M.} and Khan, {David A.}",

note = "Funding Information: Conflicts of interest: K. G, Blumenthal receives grant support from the National Institutes of Health / National Institute of Allergy and Infectious Diseases ( NIH /NIAID; R01AI150295, 2UM1AI109565-08), Phadia Ab ( Thermo Fisher Scientific ), and the Massachusetts General Hospital; personal fees for legal case review from Weekley Shulte Valdes Murman Tonelli, Piedmont Liability Trust, Vasios Kelly and Strollo PA, and Publix Supermarkets; and royalties from UpToDate, outside the submitted work. A. M. Chiriac was a member of the Advisory Board on Drug Allergy for HYCOR; and received lecture fees from Thermo Fisher Scientific . The rest of the authors declare that they have no relevant conflicts of interest. ",

year = "2023",

month = feb,

doi = "10.1016/j.jaip.2022.11.013",

language = "English (US)",

volume = "11",

pages = "429--430",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Drug Allergy

T2 - Then, Now, and Next

AU - Blumenthal, Kimberly G.

AU - Chiriac, Anca M.

AU - Khan, David A.

N1 - Funding Information: Conflicts of interest: K. G, Blumenthal receives grant support from the National Institutes of Health / National Institute of Allergy and Infectious Diseases ( NIH /NIAID; R01AI150295, 2UM1AI109565-08), Phadia Ab ( Thermo Fisher Scientific ), and the Massachusetts General Hospital; personal fees for legal case review from Weekley Shulte Valdes Murman Tonelli, Piedmont Liability Trust, Vasios Kelly and Strollo PA, and Publix Supermarkets; and royalties from UpToDate, outside the submitted work. A. M. Chiriac was a member of the Advisory Board on Drug Allergy for HYCOR; and received lecture fees from Thermo Fisher Scientific . The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85147791383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147791383&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2022.11.013

DO - 10.1016/j.jaip.2022.11.013

M3 - Editorial

C2 - 36759079

AN - SCOPUS:85147791383

SN - 2213-2198

VL - 11

SP - 429

EP - 430

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 2

ER -

Drug Allergy: Then, Now, and Next

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this